Study of a device to help access the heart during ablation
Part of Heart & circulation clinical trials.
This trial tests a new device to help doctors safely enter the left side of your heart during a procedure called ablation. If you are already scheduled for an ablation or a combined ablation and left atrial appendage closure, this study may be an option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be scheduled for an ablation procedure that involves entering the left upper chamber of the heart (left atrium) or the main pumping chamber (left ventricle), or a procedure that combines ablation with closing the left atrial appendage.
- You must be 18 years of age or older.
- You must be willing and able to give written permission to take part in the study.
- You must be able to follow all study instructions and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people who need both a special heart treatment called pulsed field ablation (FARAPULSE) and a device to close off a small pouch in the heart (WATCHMAN FLX Pro or WATCHMAN FLX) to prevent strokes. The study will see how well both procedures work when done together.
This trial is testing two ways to guide a procedure that closes a small pouch in the heart to lower the risk of stroke in people with atrial fibrillation. The goal is to see if one method is as good or better than the other.
This trial tests a new device, the Append System, to close off the left atrial appendage (a small pouch in the heart) in people with atrial fibrillation. The goal is to reduce stroke risk without needing long-term blood thinners.
This trial tests a new device called ENDOMATIC SEPIOLA that closes a small pouch in your heart (the left atrial appendage) to lower your stroke risk. It is a non-surgical option for people with atrial fibrillation who cannot take blood thinners.
This trial compares two different devices (Amplatzer Amulet and LAmbre) used to close a small pouch in the heart called the left atrial appendage. People with atrial fibrillation who are at high risk for stroke and bleeding may be able to stop blood thinners after the procedure.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
Hear when a new Left Atrial Appendage Closure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.